Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (15)

2021

  1. Effects of Colchicine on Atherosclerotic Plaque Stabilization: a Multimodality Imaging Study in an Animal Model

    Journal of Cardiovascular Translational Research, Vol. 14, Núm. 1, pp. 150-160

2018

  1. The effect of tissue-segmented attenuation maps on PET quantification with a special focus on large arteries

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 2, pp. 94-102

2015

  1. Cardiovascular imaging: What have we learned from animal models?

    Frontiers in Pharmacology, Vol. 6, Núm. OCT

2014

  1. High prevalence of occult hepatitis C virus infection in patients with primary and secondary glomerular nephropathies

    Kidney International, Vol. 86, Núm. 3, pp. 619-624

  2. Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection

    Journal of Clinical Microbiology, Vol. 52, Núm. 8, pp. 3053-3056

2011

  1. Long-term virological follow up of patients with occult hepatitis C virus infection

    Liver International, Vol. 31, Núm. 10, pp. 1519-1524

2010

  1. Diagnosis of occult hepatitis C without the need for a liver biopsy

    Journal of Medical Virology, Vol. 82, Núm. 9, pp. 1554-1559

  2. Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels

    Journal of Medical Virology, Vol. 82, Núm. 5, pp. 763-767

2009

  1. Hepatitis C virus infection in the family setting of patients with occult hepatitis C

    Journal of Medical Virology, Vol. 81, Núm. 7, pp. 1198-1203

  2. Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope

    Journal of Hepatology, Vol. 50, Núm. 2, pp. 256-263

  3. Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection

    Alimentary Pharmacology and Therapeutics, Vol. 30, Núm. 5, pp. 477-486

2004

  1. Pegylated interferon-α2a kinetics during experimental haemodialysis: Impact of permeability and pore size of dialysers

    Alimentary Pharmacology and Therapeutics, Vol. 20, Núm. 1, pp. 37-44

  2. Virus-Specific Effector CD4+ T-Cell Responses in Hemodialysis Patients with Hepatitis C Virus Infection

    Journal of Medical Virology, Vol. 72, Núm. 1, pp. 66-74

1998

  1. Tratamiento con interferon alfa linfoblastoide en pacientes con leucemia mieloide crónica resistente a interferon alfa 2 recombinante

    Sangre, Vol. 43, Núm. 5, pp. 443-447

1990

  1. Recombinant γ‐interferon as adjuvant to hepatitis B vaccine in hemodialysis patients

    Hepatology, Vol. 12, Núm. 4, pp. 661-663